Stocks BWIN Financial statements
Financial statementsBaldwin Insurance Group, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Baldwin Insurance Group, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2019 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 567 | 981 | 1,219 | 1,389 | 1,505 | |||
| Operating expenses | 127 | 140 | 139 | 183 | ||||
| Operating income | 9.53 | -5.07 | -21.9 | -31.6 | -31.1 | -42.6 | 60.6 | 73.9 |
| Other non-operating income | -6.84 | -17.4 | -7.95 | -26.5 | -44.9 | -120 | -100 | -127 |
| Pre-tax income | 2.69 | -22.4 | -29.9 | -58.1 | -76 | -163 | -39.4 | -52.4 |
| Income tax | 0 | 0.02 | -0.01 | 0.02 | 0.72 | 1.29 | 1.73 | 1.73 |
| Net income to minority interests | 3.31 | -13.8 | -14.2 | -27.5 | -35 | -73.9 | -16.6 | -20.3 |
| Net income | -0.62 | -8.65 | -15.7 | -30.6 | -41.8 | -90.1 | -24.5 | -33.8 |
| EBITDA | 12.6 | 5.48 | -1.77 | 19.9 | 55.3 | 55.9 | 170 | 202 |
| EPS, basic | -0.58 | -0.64 | -0.74 | -1.50 | -0.39 | -0.50 | ||
| EPS, diluted | -0.58 | -0.64 | -0.74 | -1.50 | -0.39 | -0.50 | ||
| Shares, basic (weighted) | 27.2 | 47.6 | 56.8 | 60.1 | 63.5 | 67.9 | ||
| Shares, diluted (weighted) | 27.2 | 47.6 | 56.8 | 60.1 | 63.5 | 67.9 |
Balance sheet
| FY2019 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 8 | 67.7 | 108 | 138 | 118 | 116 | 90 | 124 |
| Other current assets | 1.1 | 3.02 | 4.45 | 8.15 | 0.1 | 12.7 | 11.6 | 13.7 |
| Total current assets | 38.6 | 133 | 302 | 578 | 772 | 926 | 1,026 | 1,200 |
| Property, plant and equipment | 2.15 | 3.32 | 11 | 17.5 | 25.4 | 22.7 | 22 | 22.5 |
| Lease right-of-use assets | 0 | 81.6 | 96.5 | 85.5 | 72.4 | 62 | ||
| Goodwill | 65.8 | 164 | 652 | 1,229 | 1,422 | 1,412 | 1,412 | 1,517 |
| Intangible assets | 29.7 | 92.5 | 554 | 944 | 1,100 | 1,017 | 953 | 978 |
| Other non-current assets | 3.58 | 5.6 | 11.1 | 25.6 | 45.9 | 38.1 | 48 | 82.4 |
| Total assets | 140 | 399 | 1,530 | 2,876 | 3,462 | 3,502 | 3,535 | 3,862 |
| Accounts payable | 5.25 | 12.3 | 51.5 | 92.2 | 126 | 145 | 161 | 253 |
| Accrued liabilities | 0.58 | 2.53 | 13 | 9.73 | 13.1 | 23.3 | 12.4 | 57.4 |
| Deferred revenue | 1.45 | 5.35 | 11.6 | 18.2 | 31 | 30.3 | 40.8 | 36.3 |
| Short-term debt | 0.53 | 0 | 4 | 8.52 | 8.51 | 10.2 | 8.4 | 12.6 |
| Total current liabilities | 33.2 | 72.8 | 217 | 541 | 699 | 1,033 | 1,056 | 1,033 |
| Long-term debt | 1.5 | 0 | ||||||
| Lease liabilities | 0 | 71.4 | 87.7 | 79 | 68.8 | 57.7 | ||
| Other non-current liabilities | 2.61 | 2.02 | 2.42 | 3.59 | 0.16 | 0.12 | 0.06 | 0 |
| Total liabilities | 117 | 161 | 760 | 1,689 | 2,322 | 2,483 | 2,526 | 2,778 |
| Total debt | 2.02 | 0 | 399 | 8.52 | 8.51 | 10.2 | 8.4 | 12.6 |
| Paid-in capital | 0 | 82.4 | 392 | 663 | 704 | 747 | 794 | 844 |
| Retained earnings | 0 | -8.65 | -24.3 | -55 | -96.8 | -187 | -211 | -245 |
| Other comprehensive income | 0 | 0.49 | ||||||
| Shareholders' equity | -63.7 | 73.3 | 368 | 608 | 608 | 560 | 583 | 600 |
| Minority interests | 0.94 | 164 | 402 | 579 | 531 | 458 | 425 | 484 |
| Total equity | -62.8 | 237 | 770 | 1,187 | 1,140 | 1,018 | 1,008 | 1,084 |
| Total liabilities and equity | 140 | 399 | 1,530 | 2,876 | 3,462 | 3,502 | 3,535 | 3,862 |
Cash flow statement
| FY2019 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Net income | 2.69 | -22.5 | -29.9 | -58.1 | -76.7 | -164 | -41.1 | -54.2 |
| Depreciation and amortization | 3.09 | 10.5 | 20.2 | 51.5 | 86.4 | 98.4 | 109 | 128 |
| Stock-based compensation | 1.24 | 3.23 | 7.74 | 19.2 | 47.4 | 60 | 65.5 | 71.1 |
| Change in payables | 1.31 | 9 | 27.3 | 55.2 | 173 | 6.09 | -0.49 | -11.2 |
| Cash from operations | 11.8 | 12 | 36.8 | 40.1 | -2.46 | 0.05 | 51.5 | -29.4 |
| Capital expenditures | -0.53 | -1.72 | -5.47 | -5.32 | -22 | -21.4 | -41 | -39.5 |
| Acquisitions | -35.1 | -98.4 | -669 | -668 | -388 | 0 | 0 | -85.5 |
| Purchases of investments | 0 | -0.2 | -1.25 | -1.91 | -1.1 | -1.69 | -3.86 | -16.7 |
| Cash from investing | -42.5 | -101 | -678 | -678 | -414 | -21.9 | 13.3 | -140 |
| Debt repaid | -0.53 | -0.2 | ||||||
| Cash from financing | 35.6 | 152 | 712 | 724 | 420 | 18.4 | 21.1 | 204 |
| Net change in cash | 4.87 | 63.1 | 71 | 85.7 | 2.73 | -3.51 | 85.8 | 34.1 |
| Free cash flow | 11.3 | 10.3 | 31.3 | 34.8 | -24.4 | -21.3 | 10.4 | -68.9 |
| Interest paid | 3.37 | 9.49 | 5.96 | 22.1 | 62.7 | 105 | 111 | 115 |
| Income taxes paid | 0 | 0 | 1.42 | 1.43 | 2.75 | 1.7 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Operating margin | -6.9% | Operating income / revenue. |
| EBITDA margin | 4.0% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -15.8% | Pre-tax income / revenue. |
| Net margin | -4.7% | Net income / revenue. |
| FCF margin | 2.5% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 5.2% | Cash from operations / revenue. |
| Return on equity (ROE) | -9.2% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -1.3% | Net income / average total assets. |
| Return on invested capital (ROIC) | -13.2% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| Stock-based pay / revenue | 4.3% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 2.7% | Capital expenditures / revenue. |
| D&A / revenue | 10.9% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 8.3% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 15.3% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | 21.9% | Operating income vs the same period a year earlier. Only from a positive base. |
| EBITDA growth, 1y | 19.0% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 54.0% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -157.2% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow growth, 1y | -762.7% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | 2.9% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -0.4% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 10.3% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 9.3% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 3.7% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 20.3% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 7.1% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 6.1% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 20.1% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.07x | Current assets / current liabilities. |
| Quick ratio | 0.11x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.11x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.02x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 0.3% | Total debt / total assets. |
| Liabilities / assets | 77.0% | Total liabilities / total assets. |
| Net debt | -$168.4M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | -2.44x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Working capital | $125.5M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 66.4% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$3.22B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.28x | Revenue / average total assets. |
| Fixed asset turnover | 52.1x | Revenue / average property, plant and equipment. |
| Capex / operating cash flow | 51.8% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.88 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $18.73 | Revenue / diluted weighted shares. |
| FCF per share | $0.47 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.98 | Cash from operations / diluted weighted shares. |
| Book value per share | $9.53 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$34.69 | Tangible book value / shares outstanding. |
| Cash per share | $1.99 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $4.44B | Share price x shares outstanding. |
| Enterprise value | $4.27B | Market cap + total debt - cash - short-term investments. |
| P/S | 2.56x | Market cap / revenue. |
| P/B | 5.02x | Market cap / shareholders' equity. Only when equity is positive. |
| P/FCF | 102x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 48.9x | Market cap / cash from operations, when positive. |
| EV/Sales | 2.46x | Enterprise value / revenue. |
| EV/EBITDA | 62.0x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 97.8x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 1.0% | Free cash flow / market cap. |
| Earnings yield | -1.8% | Net income / market cap (the inverse of P/E). |
What was Baldwin Insurance Group, Inc.'s revenue in fiscal 2025?
Baldwin Insurance Group, Inc. reported revenue of $1.50B for fiscal 2025, 8.3% higher than the year before.
Was Baldwin Insurance Group, Inc. profitable in fiscal 2025?
No. It reported a net loss of $33.8M.
How much free cash flow did Baldwin Insurance Group, Inc. generate in fiscal 2025?
Cash from operations of $29.4M minus capital expenditures of $39.5M left free cash flow of -$68.9M.